CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CALC is expected to report earnings to fall 230.00% to -38 cents per share on November 18
Q3'26
Est.
$-0.39
Q1'26
Beat
by $0.81
Q4'25
Beat
by $1.38
Q3'25
Beat
by $1.21
Q2'25
Missed
by $7.52
The last earnings report on May 12 showed earnings per share of 30 cents, beating the estimate of -50 cents. With 122.60K shares outstanding, the current market capitalization sits at 17.61M.